Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Aug 14, 2014

30339_dirs_2014-08-14_1603e6af-9e06-42e1-ada0-eff7470d7017.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-08-13

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-13 Common Stock M 4555.0000 $20.4250 Acquired 28528.5370 Direct
2014-08-13 Common Stock S 3000.0000 $39.1300 Disposed 25528.5370 Direct
2014-08-13 Common Stock S 4555.0000 $40.0000 Disposed 20973.5370 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-13 Stock Option (Right to Buy) $20.4250 M 4555.0000 Disposed 2021-02-21 Common Stock (4555.0000) Direct